Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder
暂无分享,去创建一个
N. Volkow | G. Koob | H. Kranzler | C. Wiers | L. Vendruscolo | V. Darcey | M. T. King | Sophie K. Elvig | Vikrant R Mahajan | M. King | Valerie L. Darcey
[1] E. Day,et al. Clinical Management of the Alcohol Withdrawal Syndrome. , 2021, Addiction.
[2] C. Guerri,et al. Ketogenic Diet Decreases Alcohol Intake in Adult Male Mice , 2021, Nutrients.
[3] C. Martins,et al. Ketogenic diets and appetite regulation , 2021, Current opinion in clinical nutrition and metabolic care.
[4] Dana E. Feldman,et al. Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents , 2021, Science Advances.
[5] A. Pillai,et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease , 2021, Alzheimer's research & therapy.
[6] H. Schmidt,et al. Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder. , 2021, Drug and alcohol dependence.
[7] A. Bianco,et al. Effects of Two Months of Very Low Carbohydrate Ketogenic Diet on Body Composition, Muscle Strength, Muscle Area, and Blood Parameters in Competitive Natural Body Builders , 2021, Nutrients.
[8] A. Gjedde,et al. Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice , 2021, Psychopharmacology.
[9] J. Guigonis,et al. Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice , 2021, International journal of molecular sciences.
[10] I. Spigelman,et al. Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats , 2020, Frontiers in Neuroscience.
[11] P. Kwan,et al. Seven‐tesla quantitative magnetic resonance spectroscopy of glutamate, γ‐aminobutyric acid, and glutathione in the posterior cingulate cortex/precuneus in patients with epilepsy , 2020, Epilepsia.
[12] Yali Zhang,et al. Beta-Hydroxybutyrate Enhances BDNF Expression by Increasing H3K4me3 and Decreasing H2AK119ub in Hippocampal Neurons , 2020, Frontiers in Neuroscience.
[13] K. Verbeke,et al. Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder. , 2020, Cell reports.
[14] M. Saraga,et al. Ketogenic diet in bipolar disorder , 2020, Bipolar disorders.
[15] N. Volkow,et al. Elevated thalamic glutamate levels and reduced water diffusivity in alcohol use disorder: Association with impulsivity , 2020, Psychiatry Research: Neuroimaging.
[16] W. Węglarz,et al. MRI spectroscopic and tractography studies indicate consequences of long-term ketogenic diet , 2020, Brain Structure and Function.
[17] Yu-Chen Huang,et al. Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta‐analysis , 2020, Human psychopharmacology.
[18] Mark S. Schmidt,et al. Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease , 2020, Hepatology communications.
[19] A. McQuillin,et al. Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits , 2020, Nature Neuroscience.
[20] C. Soares,et al. Exploring the mechanisms of action of the antidepressant effect of the ketogenic diet , 2020, Reviews in the neurosciences.
[21] E. Kang,et al. SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease , 2020, Nature Communications.
[22] Samar Malaeb,et al. A Case of Hypoglycemia Associated With the Ketogenic Diet and Alcohol Use , 2020, Journal of the Endocrine Society.
[23] Syed Fahad Sultan,et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults , 2020, Proceedings of the National Academy of Sciences.
[24] M. Iwata,et al. Prefrontal cortex infusion of beta‐hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant‐like effects in a rodent model of depression , 2020, Neuropsychopharmacology reports.
[25] Étienne Myette-Côté,et al. The Impact of Acute Ingestion of a Ketone Monoester Drink on LPS-Stimulated NLRP3 Activation in Humans with Obesity , 2020, Nutrients.
[26] E. Croteau,et al. Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney , 2020, Frontiers in Nutrition.
[27] H. Berthoud,et al. FGF21 and the Physiological Regulation of Macronutrient Preference , 2020, Endocrinology.
[28] R. Veech,et al. A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer’s Disease , 2020, International journal of molecular sciences.
[29] Joseph P. Schacht,et al. Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment‐naive individuals with alcohol use disorder , 2020, Addiction biology.
[30] K. Clarke,et al. Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults. , 2019, Regulatory toxicology and pharmacology : RTP.
[31] K. Kinzig,et al. Attenuation of stress-induced weight loss with a ketogenic diet , 2019, Physiology & Behavior.
[32] F. Reimann,et al. Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet , 2019, Gut.
[33] R. Pluta,et al. Ketogenic Diet and Epilepsy , 2019, Nutrients.
[34] A. Włodarczyk,et al. Mechanisms of action of the ketogenic diet in depression , 2019, Neuroscience & Biobehavioral Reviews.
[35] A. Gyorkos,et al. Carbohydrate-restricted Diet and Exercise Increase Brain-derived Neurotrophic Factor and Cognitive Function: A Randomized Crossover Trial , 2019, Cureus.
[36] A. Kraeuter,et al. Ketogenic diet for schizophrenia: clinical implication. , 2019, Current opinion in psychiatry.
[37] N. Volkow,et al. Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity. , 2019, The international journal of neuropsychopharmacology.
[38] A. Tagliabue,et al. Long-Term Effects of a Classic Ketogenic Diet on Ghrelin and Leptin Concentration: A 12-Month Prospective Study in a Cohort of Italian Children and Adults with GLUT1-Deficiency Syndrome and Drug Resistant Epilepsy , 2019, Nutrients.
[39] G. Biagini,et al. Ghrelin Plasma Levels After 1 Year of Ketogenic Diet in Children With Refractory Epilepsy , 2019, Front. Nutr..
[40] A. Pradhan,et al. Effect of Histone Deacetylase Inhibitor on Ethanol Withdrawal-Induced Hyperalgesia in Rats , 2019, The international journal of neuropsychopharmacology.
[41] E. Westman,et al. The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies , 2019, Schizophrenia Research.
[42] J. Little,et al. Oral Ketone Supplementation Acutely Increases Markers of NLRP3 Inflammasome Activation in Human Monocytes , 2019, Molecular nutrition & food research.
[43] R. Haralick. Dependence , 2019, Pattern Recognit. Lett..
[44] E. Jerlhag,et al. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents , 2019, Psychoneuroendocrinology.
[45] K. Durkalec-Michalski,et al. Effect of a four-week ketogenic diet on exercise metabolism in CrossFit-trained athletes , 2019, Journal of the International Society of Sports Nutrition.
[46] P. Tsao,et al. Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations , 2019, Nature Communications.
[47] S. Mihic,et al. Ketone body modulation of ligand-gated ion channels , 2019, Neuropharmacology.
[48] R. Seeley,et al. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs , 2019, eNeuro.
[49] L. Good,et al. Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency , 2019, Science Translational Medicine.
[50] S. Kenig,et al. Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults. , 2019, Nutrition research.
[51] Marcella Rietschel,et al. Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river? , 2019, Psychoneuroendocrinology.
[52] M. Ota,et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease , 2019, Neuroscience Letters.
[53] R. Veech,et al. The “great” controlling nucleotide coenzymes , 2019, IUBMB life.
[54] J. Holst,et al. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys , 2018, Psychopharmacology.
[55] P. López-Jaramillo,et al. Effect of A Very Low-Calorie Ketogenic Diet on Food and Alcohol Cravings, Physical and Sexual Activity, Sleep Disturbances, and Quality of Life in Obese Patients , 2018, Nutrients.
[56] R. Bataller,et al. β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway. , 2018, Journal of hepatology.
[57] S. Masino,et al. Ketogenic Diet Modulates NAD+-Dependent Enzymes and Reduces DNA Damage in Hippocampus , 2018, Front. Cell. Neurosci..
[58] Xinliang Zhu,et al. Beta-hydroxybutyrate Promotes the Expression of BDNF in Hippocampal Neurons under Adequate Glucose Supply , 2018, Neuroscience.
[59] Matthew C L Phillips,et al. Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial , 2018, Movement disorders : official journal of the Movement Disorder Society.
[60] Kunal Sikder,et al. High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR- γ , 2018, Cellular Physiology and Biochemistry.
[61] R. Gruetter,et al. Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS , 2018, Front. Nutr..
[62] M. Rietschel,et al. Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol‐addicted subjects: a functional imaging study , 2018, Addiction biology.
[63] K. Whittingstall,et al. Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.
[64] The Oxford Handbook of Stress and Mental Health , 2018 .
[65] S. Kliewer,et al. The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol. , 2018, Cell metabolism.
[66] Sharlene D. Newman,et al. Effects of Alcohol Cues on MRS Glutamate Levels in the Anterior Cingulate , 2018, Alcohol and alcoholism.
[67] A. Lum-Jones,et al. A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder , 2018, Physiology & Behavior.
[68] K. Clarke,et al. Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals , 2018, The Journal of physiology.
[69] M. Nakazato,et al. The Homeostatic Force of Ghrelin. , 2018, Cell metabolism.
[70] L. Ferrucci,et al. Evidence for brain glucose dysregulation in Alzheimer's disease , 2018, Alzheimer's & Dementia.
[71] Yunbing Wang,et al. Ketogenic diet for treatment of intractable epilepsy in adults: A meta‐analysis of observational studies , 2018, Epilepsia open.
[72] H. Schmidt,et al. Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats , 2018, Neuropsychopharmacology.
[73] N. Volkow,et al. Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats , 2018, Alcoholism, clinical and experimental research.
[74] E. Tai,et al. A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men , 2018, PloS one.
[75] R. Swerdlow,et al. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease , 2017, Alzheimer's & dementia.
[76] K. Clarke,et al. A Ketone Ester Drink Lowers Human Ghrelin and Appetite , 2017, Obesity.
[77] R. Seeley,et al. Dietary Manipulations That Induce Ketosis Activate the HPA Axis in Male Rats and Mice: A Potential Role for Fibroblast Growth Factor-21 , 2018, Endocrinology.
[78] S. Masino,et al. Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? , 2017, Front. Mol. Neurosci..
[79] A. Fink-Jensen,et al. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice , 2017, Pharmacology Biochemistry and Behavior.
[80] Nora D. Volkow,et al. Neurochemical and metabolic effects of acute and chronic alcohol in the human brain: Studies with positron emission tomography , 2017, Neuropharmacology.
[81] T. Horvath,et al. Ghrelin is Supressed by Intravenous Alcohol and is Related to Stimulant and Sedative Effects of Alcohol , 2017, Alcohol and alcoholism.
[82] E. Croteau,et al. Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[83] R. Jankord,et al. Nutritional Ketosis Affects Metabolism and Behavior in Sprague-Dawley Rats in Both Control and Chronic Stress Environments , 2017, Front. Mol. Neurosci..
[84] J. Rehfeld,et al. Timeline of changes in appetite during weight loss with a ketogenic diet , 2017, International Journal of Obesity.
[85] A. Dixon,et al. Mitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome☆ , 2017, Redox biology.
[86] M. Mattson,et al. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease , 2017, Journal of neurochemistry.
[87] E. Kossoff,et al. Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. , 2017, Pediatric neurology.
[88] Ann K. Shinn,et al. Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement , 2017, Schizophrenia bulletin.
[89] G. Juhász,et al. Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats , 2016, Front. Mol. Neurosci..
[90] G. Juhász,et al. Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats , 2016, Front. Mol. Neurosci..
[91] M. Mattson,et al. 3‐Hydroxybutyrate regulates energy metabolism and induces BDNF expression in cerebral cortical neurons , 2016, Journal of neurochemistry.
[92] P. Jolliet,et al. Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence? , 2016, Expert opinion on drug safety.
[93] S. Neubauer,et al. Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. , 2016, Cell metabolism.
[94] K. Reynolds,et al. The effects of a low-carbohydrate diet on appetite: A randomized controlled trial. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[95] Sama F. Sleiman,et al. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate , 2016, eLife.
[96] Bhavna S. Paratala,et al. FGF21 Regulates Sweet and Alcohol Preference. , 2016, Cell Metabolism.
[97] R. Judd,et al. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. , 2016, Metabolism: clinical and experimental.
[98] P. Maccioni,et al. The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents , 2015, Addiction biology.
[99] E. Verdin. NAD+ in aging, metabolism, and neurodegeneration , 2015, Science.
[100] V. Karpyak,et al. Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. , 2015, Drug and alcohol dependence.
[101] K. Hashimoto,et al. BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms , 2015, Translational Psychiatry.
[102] I. Torres,et al. Protracted alcohol abstinence induces analgesia in rats: Possible relationships with BDNF and interleukin-10 , 2015, Pharmacology Biochemistry and Behavior.
[103] R. Sun,et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice. , 2015, Journal of hepatology.
[104] N. Dilbaz,et al. Relationship between craving and ghrelin, adiponectin, and resistin levels in patients with alcoholism. , 2015, Alcoholism, clinical and experimental research.
[105] Kamil Ugurbil,et al. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences , 2015, Proceedings of the National Academy of Sciences.
[106] A. Gasbarrini,et al. Identification and Management of Alcohol Withdrawal Syndrome , 2015, Drugs.
[107] P. A. Crawford,et al. Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.
[108] F. Liu,et al. The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro , 2015, Free radical research.
[109] F. Greenway,et al. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial , 2015, BBA clinical.
[110] Xiaojia Li,et al. Efficacy of and Patient Compliance with a Ketogenic Diet in Adults with Intractable Epilepsy: A Meta-Analysis , 2015, Journal of clinical neurology.
[111] T. Vanitallie,et al. A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease , 2015, Alzheimer's & Dementia.
[112] Leah C. S. Cepko,et al. Ghrelin alters the stimulatory effect of cocaine on ethanol intake following mesolimbic or systemic administration , 2014, Neuropharmacology.
[113] K. Kiianmaa,et al. Innate BDNF expression is associated with ethanol intake in alcohol-preferring AA and alcohol-avoiding ANA rats , 2014, Brain Research.
[114] E. Jerlhag,et al. Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy , 2014, CNS Drugs.
[115] D. Moller,et al. FGF21-based pharmacotherapy – potential utility for metabolic disorders , 2014, Trends in Endocrinology & Metabolism.
[116] M. Tamura,et al. Acetaldehyde is an oxidative stressor for gastric epithelial cells , 2014, Journal of clinical biochemistry and nutrition.
[117] H. Chen,et al. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages , 2014, Nature Communications.
[118] H. Kranzler,et al. Pharmacotherapy of alcohol use disorders: seventy-five years of progress. , 2014, Journal of studies on alcohol and drugs. Supplement.
[119] P. Mulholland,et al. Neurochemical mechanisms of alcohol withdrawal. , 2014, Handbook of clinical neurology.
[120] G. Núñez,et al. Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice , 2013, Mediators of inflammation.
[121] R. El-Mallakh,et al. The ketogenic diet for type II bipolar disorder , 2013, Neurocase.
[122] G. Szabo,et al. Alcohol‐induced IL‐1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation , 2013, Journal of leukocyte biology.
[123] Walter Heindel,et al. Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex , 2013, Neuropsychopharmacology.
[124] A. Shulkes,et al. Ketosis and appetite-mediating nutrients and hormones after weight loss , 2013, European Journal of Clinical Nutrition.
[125] S. Kliewer,et al. FGF21 regulates circadian behavior and metabolism by acting on the nervous system , 2013, Nature medicine.
[126] M. Mattson,et al. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.
[127] C. Gonçalves,et al. Brain changes in BDNF and S100B induced by ketogenic diets in Wistar rats. , 2013, Life sciences.
[128] Jean Martinez,et al. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference , 2013, Peptides.
[129] John H Krystal,et al. Increased brain uptake and oxidation of acetate in heavy drinkers. , 2013, The Journal of clinical investigation.
[130] E. Wirrell,et al. Ketogenic Diet , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[131] Gary Yellen,et al. The ketogenic diet: metabolic influences on brain excitability and epilepsy , 2013, Trends in Neurosciences.
[132] Eric Verdin,et al. Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.
[133] Nora D. Volkow,et al. Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain , 2013, NeuroImage.
[134] J. Kim,et al. The effects of alcohol abstinence on BDNF, ghrelin, and leptin secretions in alcohol-dependent patients with glucose intolerance. , 2013, Alcoholism, clinical and experimental research.
[135] R. Lecomte,et al. The ketogenic diet increases brain glucose and ketone uptake in aged rats: A dual tracer PET and volumetric MRI study , 2012, Brain Research.
[136] P. Llorca,et al. Alteration of glutamate/GABA balance during acute alcohol withdrawal in emergency department: a prospective analysis. , 2012, Alcohol and alcoholism.
[137] D. Meyerhoff,et al. Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. , 2012, Drug and alcohol dependence.
[138] T. Vanitallie,et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.
[139] Patrice D Cani,et al. The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects , 2012, PloS one.
[140] A. Koopmann,et al. The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals , 2012, Psychoneuroendocrinology.
[141] M. Daglish,et al. Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment. , 2012, Nutrition.
[142] A. Sartorius,et al. Translational Magnetic Resonance Spectroscopy Reveals Excessive Central Glutamate Levels During Alcohol Withdrawal in Humans and Rats , 2012, Biological Psychiatry.
[143] P. Monteleone,et al. Ghrelin system in alcohol‐dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving , 2012, Addiction biology.
[144] S. Bloom,et al. Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity , 2012, Gut and liver.
[145] Tatiana Foroud,et al. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry , 2011, Molecular Psychiatry.
[146] A. Cederbaum. Alcohol Metabolism , 2020, Encyclopedia of Gastroenterology.
[147] A. Sakharkar,et al. Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. , 2012, Alcoholism, clinical and experimental research.
[148] F. Dalmay,et al. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. , 2011, Alcoholism, clinical and experimental research.
[149] K. Behar,et al. 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans , 2011, NMR in biomedicine.
[150] E. Castrén,et al. Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice , 2011, Neuroscience Letters.
[151] R. Thoma,et al. Perturbation of the Glutamate–Glutamine System in Alcohol Dependence and Remission , 2011, Neuropsychopharmacology.
[152] R. Nicoll,et al. Metabolic Control of Vesicular Glutamate Transport and Release , 2010, Neuron.
[153] S. Kliewer,et al. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. , 2010, Molecular endocrinology.
[154] M. Martínez-Chantar,et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. , 2010, Gastroenterology.
[155] J. Flier,et al. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. , 2009, Endocrinology.
[156] P. Janak,et al. Endogenous BDNF in the Dorsolateral Striatum Gates Alcohol Drinking , 2009, The Journal of Neuroscience.
[157] F. Karpe,et al. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. , 2009, The Journal of clinical endocrinology and metabolism.
[158] L. Costantini,et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.
[159] B. Ham,et al. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. , 2009, Alcohol.
[160] A. Sakharkar,et al. Neuroscience of alcoholism: molecular and cellular mechanisms , 2009, Cellular and Molecular Life Sciences.
[161] Yan Zeng,et al. Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[162] J. Wheless. History of the ketogenic diet , 2008, Epilepsia.
[163] M. Eriksson,et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. , 2008, Cell metabolism.
[164] J. Cross,et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.
[165] P. de Timary,et al. Alcohol dependence is associated with reduced plasma and fundic ghrelin levels , 2008, European journal of clinical investigation.
[166] J. Pedraza-Chaverri,et al. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions , 2008, Experimental Neurology.
[167] Ming-Chyi Huang,et al. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. , 2008, Alcohol and alcoholism.
[168] R. Ugale,et al. Brain Chromatin Remodeling: A Novel Mechanism of Alcoholism , 2008, The Journal of Neuroscience.
[169] Margaret I Davis. Ethanol-BDNF interactions: still more questions than answers. , 2008, Pharmacology & therapeutics.
[170] Yong-Ku Kim,et al. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. , 2007, Alcoholism, clinical and experimental research.
[171] J. Holst. The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.
[172] J. Rho,et al. Ketone bodies are protective against oxidative stress in neocortical neurons , 2007, Journal of neurochemistry.
[173] G. Yellen,et al. Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening KATP Channels , 2007, The Journal of Neuroscience.
[174] J. Rho,et al. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation , 2007, Neuroscience.
[175] E. Nestler,et al. Neurotrophic mechanisms in drug addiction , 2007, NeuroMolecular Medicine.
[176] E. Capristo,et al. Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. , 2006, Alcoholism, clinical and experimental research.
[177] E. Mezey,et al. Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. , 2006, Alcoholism: Clinical and Experimental Research.
[178] J. Kornhuber,et al. Ghrelin levels are increased in alcoholism. , 2005, Alcoholism, clinical and experimental research.
[179] D. Connolly,et al. (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G* , 2005, Journal of Biological Chemistry.
[180] A. Convit,et al. Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.
[181] D. Crabb,et al. The role of AMP-activated protein kinase in the action of ethanol in the liver. , 2004, Gastroenterology.
[182] C. Bondy,et al. Caloric restriction augments brain glutamic acid decarboxylase‐65 and ‐67 expression , 2004, Journal of neuroscience research.
[183] M. Reger,et al. Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.
[184] M. Vila,et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.
[185] J. Smeitink,et al. Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study , 2003, Journal of child neurology.
[186] N. Volkow,et al. Alcohol intoxication induces greater reductions in brain metabolism in male than in female subjects. , 2003, Alcoholism, clinical and experimental research.
[187] G. Frost,et al. Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[188] K. Clarke,et al. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[189] J. Thoen,et al. Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. , 2000, Clinical and experimental rheumatology.
[190] J M Freeman,et al. A multicenter study of the efficacy of the ketogenic diet. , 1998, Archives of neurology.
[191] S. Woods,et al. Signals that regulate food intake and energy homeostasis. , 1998, Science.
[192] R. Saitz,et al. Pharmacotherapies for alcohol abuse. Withdrawal and treatment. , 1997, The Medical clinics of North America.
[193] G. Radda,et al. Insulin, ketone bodies, and mitochondrial energy transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[194] T. Hirano,et al. Mitochondrial glutathione depletion in alcoholic liver disease. , 1993, Alcohol.
[195] E. Vining,et al. Efficacy of the Ketogenic Diet for Intractable Seizure Disorders: Review of 58 Cases , 1992, Epilepsia.
[196] R. Derr,et al. Separation of the tremorous and muscular rigidity components of the ethanol withdrawal syndrome in the rat , 1986, Physiology & Behavior.
[197] J. Haxby,et al. Positron emission tomography in normal aging and Alzheimer's disease. , 1984, Psychopharmacology bulletin.
[198] A. Cederbaum,et al. Transfer and reoxidation of reducing equivalents as the rate-limiting steps in the oxidation of ethanol by liver cells isolated from fed and fasted rats. , 1977, Archives of biochemistry and biophysics.
[199] P. Huttenlocher,et al. Medium‐chain triglycerides as a therapy for intractable childhood epilepsy , 1971, Neurology.
[200] C. Lieber,et al. Effect of ethanol on ketone metabolism. , 1970, The Journal of clinical investigation.
[201] G. Freund,et al. Standardized ketosis in man following medium chain triglyceride ingestion. , 1966, Metabolism: clinical and experimental.
[202] H. Krebs,et al. THE METABOLISM OF GLUTAMATE IN HOMOGENATES AND SLICES OF BRAIN CORTEX. , 1963, The Biochemical journal.
[203] P. O'hollaren. Diphosphopyridine nucleotide in the prevention, diagnosis and treatment of drug addiction. A preliminary report. , 1961, Western journal of surgery, obstetrics, and gynecology.